Harrow (HROW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Harrow (HROW) is projected to report Q2 2025 earnings of $0.00 per share, a 100% year-over-year increase, on revenues of $65.32 million, up 33.5%. However, the consensus EPS estimate has been revised 7.89% lower over the past 30 days, and a negative Zacks Earnings ESP of -1,000.01% suggests recent bearish analyst sentiment. This, combined with a Zacks Rank #3 and a significant earnings miss last quarter, indicates a low probability of an earnings beat for the pharmaceutical company ahead of its August 11 release.

Analysis

Harrow (HROW) is approaching its Q2 2025 earnings release with a mixed but predominantly cautious outlook. On one hand, consensus estimates project significant year-over-year growth, with revenues expected to increase 33.5% to $65.32 million and EPS forecasted to improve 100% to reach breakeven at $0.00 per share. However, several leading indicators suggest a high probability of the company failing to meet these expectations. The consensus EPS estimate has been revised downward by 7.89% over the last 30 days, indicating weakening analyst confidence. This bearish sentiment is amplified by a highly negative Zacks Earnings ESP of -1,000.01%, which signifies that the most recent analyst estimates are substantially below the broader consensus. Furthermore, the company's recent track record is a concern; it missed its last quarterly EPS estimate by a staggering 2,000% and has only surpassed consensus EPS estimates twice in the last four quarters. The combination of a neutral Zacks Rank #3 (Hold) with a strongly negative ESP makes a positive earnings surprise unlikely.

Key Decisions for Investors

• Given the conflicting signals of strong year-over-year growth projections against sharply negative recent analyst revisions and a poor ESP reading, investors should exercise caution ahead of the August 11 earnings report.
• The significant -2,000% earnings surprise miss last quarter highlights considerable execution risk; focus should be placed on management's guidance and commentary during the earnings call to assess the sustainability of its revenue growth and path to profitability.
• Considering the company does not appear to be a compelling earnings-beat candidate based on the provided metrics, holding a speculative bullish position through the earnings event carries elevated risk of a negative price reaction.